The Residual Center of Mass: An Image Descriptor for the Diagnosis of Alzheimer Disease
A crucial quest in neuroimaging is the discovery of image features (biomarkers) associated with neurodegenerative disorders. Recent works show that such biomarkers can be obtained by image analysis techniques. However, these techniques cannot be directly compared since they use different databases and validation protocols. In this paper, we present an extensive study of image descriptors for the diagnosis of Alzheimer Disease (AD) and introduce a new one, named Residual Center of Mass (RCM). The RCM descriptor explores image moments and other techniques to enhance brain regions and select discriminative features for the diagnosis of AD. For validation, a Support Vector Machine (SVM) is trained with the selected features to classify images from normal subjects and patients with AD. We show that RCM with SVM achieves the best accuracies on a considerable number of exams by 10-fold cross-validation — 95.1% on 507 FDG-PET scans and 90.3% on 1374 MRI scans.
KeywordsDiagnosis Neuroimaging Alzheimer disease Machine learning Support vector machine Image analysis Biomarker
We thank Instituto de Pesquisas Eldorado, FAPESP (grant number 14/12236-1) and CNPq (grant number 302970/2014-2) for financial support. Data collection and sharing for this project was funded by the Alzheimer’s Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer’s Association; Alzheimer’s Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer’s Therapeutic Research Institute at the University of Southern California. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California.
- Alzheimer’s Association. (2017). Alzheimer’s disease and dementia. http://www.alz.org/. [Online; accessed 20 Dec 2017].
- Ambastha, A.K. (2015). Neuroanatomical characterisation of Alzheimer’s disease using deep learning. National University of Singapore.Google Scholar
- Association, A.E.R., Association, A.P., on Measurement in Education, N.C., on Standards for Educational, J.C., (US), P.T. (1999). Standards for educational and psychological testing. American Educational Research Association.Google Scholar
- Chen, Y.W., & Lin, C.J. (2006). Combining SVMs with various feature selection strategies. In Feature extraction (pp. 315–324). Springer.Google Scholar
- Costafreda, S.G., Fu, C.H., Picchioni, M., Toulopoulou, T., McDonald, C., Kravariti, E., Walshe, M., Prata, D., Murray, R.M., McGuire, P.K. (2011). Pattern of neural responses to verbal fluency shows diagnostic specificity for schizophrenia and bipolar disorder. BMC Psychiatry, 11(1), 1.CrossRefGoogle Scholar
- French, A., Macedo, M., Poulsen, J., Waterson, T., Yu, A. (2017). Multivariate analysis of variance (MANOVA). http://userwww.sfsu.edu/efc/classes/biol710/manova/MANOVAnewest.pdf. [Online; accessed 20 Dec 2017].
- Golugula, A., Lee, G., Madabhushi, A. (2011). Evaluating feature selection strategies for high dimensional, small sample size datasets. In 2011 Annual International conference of the IEEE engineering in medicine and biology society (pp. 949–952). IEEE.Google Scholar
- Grünauer, A., & Vincze, M. (2015). Using dimension reduction to improve the classification of high-dimensional data. arXiv:1505.06907.
- Gupta, A., Ayhan, M., Maida, A. (2013). Natural image bases to represent neuroimaging data. In ICML (Vol. 3, pp. 987–994).Google Scholar
- Halldestam, M. (2016). ANOVA-the effect of outliers.Google Scholar
- Heijmans, H.J., & Roerdink, J. (1998). Mathematical morphology and its applications to image and signal processing (Vol. 12). Springer Science & Business Media.Google Scholar
- Jenkinson, M., Pechaud, M., Smith, S. (2005). BET2: MR-based estimation of brain, skull and scalp surfaces. In: Eleventh annual meeting of the organization for human brain mapping (Vol. 17, p. 167).Google Scholar
- Klöppel, S., Stonnington, C.M., Barnes, J., Chen, F., Chu, C., Good, C.D., Mader, I., Mitchell, L.A., Patel, A.C., Roberts, C.C., et al. (2008). Accuracy of dementia diagnosis - a direct comparison between radiologists and a computerized method. Brain: A Journal of Neurology, 131(11), 2969–2974.CrossRefGoogle Scholar
- Kramer, O. (2016). Scikit-learn. In Machine learning for evolution strategies (pp. 45–53). Springer.Google Scholar
- Landini, L., Positano, V., Santarelli, M. (2005). Advanced image processing in magnetic resonance imaging. CRC Press.Google Scholar
- Payan, A., & Montana, G. (2015). Predicting Alzheimer’s disease: a neuroimaging study with 3d convolutional neural networks. arXiv:1502.02506.
- Rao, A., Lee, Y., Gass, A., Monsch, A. (2011). Classification of Alzheimer’s disease from structural MRI using sparse logistic regression with optional spatial regularization. In 2011 Annual International conference of the IEEE engineering in medicine and biology society, EMBC (pp. 4499–4502). IEEE.Google Scholar
- Russ, J.C. (2016). The image processing handbook. CRC Press.Google Scholar
- Segovia, F., Ramírez, J., Górriz, J.M., Chaves, R., Salas-Gonzalez, D., López, M., Álvarez, I., Padilla, P., Puntonet, C.G. (2010). Partial least squares for feature extraction of SPECT images. In International Conference on hybrid artificial intelligence systems (pp. 476–483). Springer.Google Scholar
- Sensi, F., Rei, L., Gemme, G., Bosco, P., Chincarini, A. (2014). Global disease index, a novel tool for MTL atrophy assessment. In MICCAI workshop challenge on computer-aided diagnosis of dementia based on structural MRI data (pp. 92–100).Google Scholar
- Somasundaram, K., & Genish, T. (2014). The extraction of hippocampus from MRI of human brain using morphological and image binarization techniques. In 2014 International Conference on electronics and communication systems (ICECS) (pp. 1–5). IEEE.Google Scholar
- Walter, B., Blecker, C., Kirsch, P., Sammer, G., Schienle, A., Stark, R., Vaitl, D. (2003). MARINA: an easy to use tool for the creation of MAsks for Region of INterest analyses. In 9th International conference on functional mapping of the human brain (Vol. 19).Google Scholar
- Wenlu, Y., Fangyu, H., Xinyun, C., Xudong, H. (2011). ICA-based automatic classification of PET images from ADNI database. In International Conference on neural information processing (pp. 265–272). Springer.Google Scholar
- World Health Organization. (2017). Dementia fact sheet. http://www.who.int/mediacentre/factsheets/fs362/en/. [Online; accessed 20 Dec 2017].